Nuclear morphometry is a superior prognostic predictor in comparison to histological grading in renal cell carcinoma:A retrospective clinico-pathological study

---

Original Article

Author Details : Shruti Agrawal*, Nikunj Jain

Volume : 9, Issue : 3, Year : 2022

Article Page : 208-215

https://doi.org/10.18231/j.ijpo.2022.051

Suggest article by email

Get Permission

---

Abstract

Renal cell carcinoma (RCC) is a spectrum of clinico-pathologically distinct entities thereby making it difficult to accurately predict the clinical outcome. Subjectivity and lack of reproducibility in nuclear grade mandates use of more objective parameters like nuclear morphometry. Out of 219 cases of RCC, nuclear grading was done in 181 cases and digital morphometry was done in 100 cases. Nuclear grade and morphometric parameters were correlated statistically with the clinical outcome of the patients. Histological nuclear grade did not show statistically significant correlation with progression free survival (PFS). Higher values of morphometric parameters were significant predictors of PFS with a strong inverse correlation. Nuclear morphometry is a more reliable predictor of clinical outcome in patients of RCC when compared to histological grade and should be included in predictive model with other clinical and pathological parameters to accurately determine tumor behaviour.
 

Keywords: Renal cell carcinoma, Nuclear morphometry, Fuhrman nuclear grade.

How to cite : Agrawal S, Jain N, Nuclear morphometry is a superior prognostic predictor in comparison to histological grading in renal cell carcinoma:A retrospective clinico-pathological study. Indian J Pathol Oncol 2022;9(3):208-215

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.